RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc., (OTCPK: FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the launch of the Sterizo Total Knee Replacement System, the latest addition to a comprehensive line of orthopedic product offerings.

The Sterizo Total Knee System is a next generation technology platform based on proven and accepted design principles in the orthopedic total knee arthroplasty marketplace. Its high flexion engineered, multi radius design delivers exceptional range of motion. The Sterizo Total Knee System offers a full range of sizes as well as multiple stabilization options, including, Cruciate Retained, Ultra Congruent Anterior Stabilized and Posterior Stabilized.

The Sterizo Total Knee System utilizes a streamlined, stackable, two tray modular instrument system for simplicity and to help reduce sterile processing costs. The intelligent design of the Sterizo Total Knee System provides for an improved approach to completing a total knee arthroplasty with great efficiency.

“We are excited to expand our orthopedic product portfolio and national distribution footprint with the addition of the Sterizo Total Knee Replacement System,” commented Christopher C. Reeg, Chief Executive Officer of Fuse. “The launch of this technology will present surgeons with advanced options for treatment of their patients requiring total knee arthroplasty. Our primary knee offering will be followed next year by the launch of a comprehensive revision knee system, as well a primary total hip system, highlighting our commitment to advance our competitive product portfolio in the orthopedic marketplace. The Sterizo Total Knee System also provides new opportunities for independent distributors nationwide. Our priority at Fuse is to provide effective solutions for today’s clinical challenges and assist with improving surgical outcomes.”

About Fuse Medical, Inc.

Fuse is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace. Fuse provides a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as, degenerative and deformity spine, Orthobiologics and regenerative medicine. For more information about the Company, or if you’re interested in becoming a new distributor for the Sterizo Total Knee System, please contact us at or visit:

Forward Looking Statements

Certain statements in this press release, constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend,” or similar expressions or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based only on information available to the Company as of the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including, without limitation, those set forth in the Company’s filings with the Securities and Exchange Commission; the failure of the Company to close the transaction; and integration issues with the consolidated company. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events, or otherwise, except as required by law.


Fuse Medical, Inc.
Devon Morgan, Sr. Investor Relations Analyst
Office (469) 862-3030
Facsimile (469) 862-3035